Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., has announced a partnership with Harrow, a leading North American eyecare company, to launch an authorized generic of Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension), which treats and relieves bacterial eye infections. The product is a great addition to Nordic Pharma's generic portfolio, providing patients another affordable prescription option.